Results

Total Results: 1,801 records

Showing results for "testing".

21. Archived: Letter to the Editor and Response from the Evidence-Based Practice Center: Human Papillomavirus Testing to Screen for Cervical Cancer: Cervical Cancer: Screening | United States Preventive Services Taskforce
    www.uspreventiveservicestaskforce.org/uspstf/document/letter-to-the-editor-and-response-from-the-evidence-based-practice-center--human-papillomavirus-testing-to-screen-for-cervical-cancer/cervical-cancer-screening-2012
    February 15, 2012 - Letter to the Editor and Response from the Evidence-Based Practice Center: Human Papillomavirus Testing … (Table 3 of the report) indicating that HPV testing is able to detect non-regressive lesions earlier … As the protective effect is similar with all strategies, the least costly (HPV testing with cytology … Human papillomavirus testing in the prevention of cervical cancer. … Cervical cancer screening with both human papillomavirus and Papanicolaou testing vs Papanicolaou testing

22. Evidence Summary: Chlamydia and Gonorrhea: Screening | United States Preventive Services Taskforce
    www.uspreventiveservicestaskforce.org/uspstf/document/final-evidence-summary/chlamydia-and-gonorrhea-screening
    September 14, 2021 - Sensitivity of gonococcal testing was 89% or greater for all anatomical samples. … False-positive and false-negative testing rates were low across anatomical sites and collection methods … Testing for asymptomatic chlamydial and gonococcal infections was highly accurate at most anatomical … The sensitivity of urine testing was more variable than anatomical site testing in 5 studies (range, … in males, false-positive rates were 0.4% for meatal testing 19 and 0.3% to 0.7% for urine testing,

23. Final Research Plan: Chlamydia and Gonorrhea: Screening | United States Preventive Services Taskforce
    www.uspreventiveservicestaskforce.org/uspstf/document/final-research-plan/chlamydia-and-gonorrhea-screening
    May 02, 2019 - Screening strategies include testing for concurrent sexually transmitted infections, including HIV, or … What is the diagnostic accuracy of anatomic site–specific testing and collection methods for identifying … ) or other reference standard (if study does not use nucleic acid amplification testing), specific to … , and the included risk groups and risk behaviors; clarified the gold standard for testing as nucleic … acid amplification testing (or other standards reported by studies if nucleic acid amplification testing

24. Archived: Evidence Summary: BRCA-Related Cancer: Risk Assessment, Genetic Counseling, and Genetic Testing | United States Preventive Services Taskforce
    www.uspreventiveservicestaskforce.org/uspstf/document/evidence-summary17/brca-related-cancer-risk-assessment-genetic-counseling-and-genetic-testing-2013
    December 15, 2013 - by selective testing of high-risk persons. … Data were not available to determine the optimum age for testing and how the age at testing influences … Risk factor analysis and implications for genetic testing. JAMA . 1997;278:1242-50. … BRCA1 gene testing. … Benefit finding in response to BRCA1/2 testing. Ann Behav Med . 2008;35:61-9.

25. Archived: Cervical Cancer: Screening | United States Preventive Services Taskforce
    www.uspreventiveservicestaskforce.org/uspstf/recommendation/cervical-cancer-screening-2012
    March 15, 2012 - Grade: A Screen with cytology every 3 years or co-testing (cytology/HPV testing) every 5 years. … The benefits of screening with co-testing (cytology/HPV testing) every 5 years outweigh the harms. … Among women age 30 to 65 years, HPV testing combined with cytology (co-testing) every 5 years offers … may increase with HPV testing. … Women age 30 to 65 years should be screened with cytology and HPV testing (co-testing) every 5 years

26. Liquid-Based Cytology and Human Papillomavirus Testing to Screen for Cervical Cancer: A Systematic Review for the U.S. Preventive Services Task Force (pdf file)
    www.uspreventiveservicestaskforce.org/home/getfilebytoken/_9KLmyQyMnoE3agQJsgNE-
    November 01, 2011 - primary screening with HPV testing alone, primary HPV testing with cytology triage of positive HPV (reflex … Harms of HPV Testing Human papillomavirus testing could increase harms rel- ative to cytology by increasing … Efficacy of HPV DNA testing with cytology triage and/or repeat HPV DNA testing in primary cervical cancer … Human papillomavirus testing in the prevention of cervical cancer. … Cervical cancer screening with both human papillomavirus and Papanicolaou testing vs Papanicolaou testing

27. Archived: Breast and Ovarian Cancer: BRCA Genetic Testing, September 2005 | United States Preventive Services Taskforce
    www.uspreventiveservicestaskforce.org/uspstf/recommendation/breast-and-ovarian-cancer-brca-testing-screening-2005
    September 15, 2005 - archived Final Recommendation Statement Breast and Ovarian Cancer: BRCA Genetic Testing … Update in Progress for BRCA-Related Cancer: Risk Assessment, Genetic Counseling, and Genetic Testing … against routine referral for genetic counseling or routine breast cancer susceptibility gene (BRCA) testing … The impact of BRCA testing on ethical, legal, and social issues needs to be better clarified. … Risk factor analysis and implications for genetic testing. JAMA 1997;278:1242-50.

28. Modeling Study: Cervical Cancer: Screening | United States Preventive Services Taskforce
    www.uspreventiveservicestaskforce.org/uspstf/document/modeling-study/cervical-cancer-screening
    August 21, 2018 - hrHPV testing with cytology triage. … to hrHPV testing or cotesting. … testing alone and cotesting. … Human papillomavirus testing 2007-2012: co-testing and triage utilization and impact on subsequent clinical … but not diagnostic (ie, colposcopy and biopsy) testing.

29. Inactive: Elevated Blood Lead Levels in Children and Pregnant Women: Screening | United States Preventive Services Taskforce
    www.uspreventiveservicestaskforce.org/uspstf/recommendation/elevated-blood-lead-levels-in-childhood-and-pregnancy-screening
    April 30, 2024 - The USPSTF recognizes the importance of screening and testing for blood lead levels in children and … Committee on Childhood Lead Poisoning Prevention (ACCLPP) has made recommendations on screening and testing … The methods used by the CDC and the ACCLPP to review evidence on screening and testing may differ from … The CDC’s recommendations on screening and testing for elevated lead levels in children and pregnant

30. Screening for Cervical Cancer: USPSTF Recommendation Statement (pdf file)
    www.uspreventiveservicestaskforce.org/home/getfilebytoken/-6kN7TPcfEj2owG4GTN2jA
    June 01, 2012 - The benefits of screening with co-testing (cytology/HPV testing) every 5 years outweigh the harms … to 65 Years Women Aged 21 Women Aged 30 HPV testing combined with cytology (co-testing) every 5 years … Among women aged 30 to 65 years, HPV testing combined with cytology (co-testing) every 5 years offers … may increase with HPV testing. … Women aged 30 to 65 years should be screened with cytology and HPV testing (co-testing) every 5 years

31. Screening for Cervical Cancer (pdf file)
    www.uspreventiveservicestaskforce.org/home/getfilebytoken/TEqfQsqZ92eykPeTQBZx-h
    March 12, 2012 - Grade: A Screen with cytology every 3 years or co-testing (cytology/HPV testing) every 5 years … Grade: D Do not screen with HPV testing (alone or with cytology) Grade: D Risk Assessment … HPV testing combined with cytology (co-testing) every 5 years in women ages 30 to 65 years offers a comparable … The benefits of screening with co-testing (cytology/HPV testing) every 5 years outweigh the harms … The potential harms of screening with HPV testing (alone or with cytology) outweigh the potential

32. Final Research Plan: Risk Assessment, Genetic Counseling, and Genetic Testing for BRCA-Related Cancer | United States Preventive Services Taskforce
    www.uspreventiveservicestaskforce.org/uspstf/announcements/final-research-plan-risk-assessment-genetic-counseling-and-genetic-testing-brca-related-cancer
    August 24, 2017 - Final Research Plan: Risk Assessment, Genetic Counseling, and Genetic Testing for BRCA-Related Cancer … Services Task Force posted today a final research plan on risk assessment, genetic counseling, and genetic testing … please go to  /uspstf/recommendation/brca-related-cancer-risk-assessment-genetic-counseling-and-genetic-testing

33. U.S. Preventive Services Task Force Issues Final Recommendation Statement for Risk Assessment, Genetic Counseling, and Genetic Testing for BRCA-Related Cancer in Women | United States Preventive Services Taskforce
    www.uspreventiveservicestaskforce.org/uspstf/announcements/us-preventive-services-task-force-issues-final-recommendation-statement-risk-assessment-genetic-counseling-and-genetic-testing-brca
    December 24, 2013 - Task Force Issues Final Recommendation Statement for Risk Assessment, Genetic Counseling, and Genetic Testing … released today a final Recommendation Statement on risk assessment, genetic counseling, and genetic testing … please go to /uspstf/recommendation/brca-related-cancer-risk-assessment-genetic-counseling-and-genetic-testing

34. Draft Research Plan: Obstructive Sleep Apnea in Adults: Screening | United States Preventive Services Taskforce
    www.uspreventiveservicestaskforce.org/uspstf/document/draft-research-plan/obstructive-sleep-apnea-adults-screening
    December 17, 2020 - tools, and multistep screening approaches (e.g., using a questionnaire followed by home-based oximetry/testing … What are the harms associated with screening or subsequent diagnostic testing for OSA, including for … What are the barriers to undergoing diagnostic testing for OSA (e.g., availability of polysomnography … , ability to tolerate testing)? … How often do those barriers prevent completion of testing?

35. Genetic Risk Assessment and BRCA Mutation Testing for Breast and Ovarian Cancer Susceptibility: Recommendation Statement (pdf file)
    www.uspreventiveservicestaskforce.org/home/getfilebytoken/ER_LzXdmdRcZ463r4UrGtz
    September 01, 2005 - Genetic Risk Assessment and BRCA Mutation Testing for Breast and Ovarian Cancer Susceptibility: Recommendation … Statement Genetic Risk Assessment and BRCA Mutation Testing for Breast and Ovarian Cancer Susceptibility … Genetic risk assessment and BRCA mutation testing for breast and ovarian cancer susceptibility. … The impact of BRCA testing on ethical, legal, and social issues needs to be better clarified. … Risk factor analysis and implications for genetic testing. JAMA. 1997; 278:1242-50.

36. Archived: Evidence Summary: Breast and Ovarian Cancer: BRCA Genetic Testing, September 2005 | United States Preventive Services Taskforce
    www.uspreventiveservicestaskforce.org/uspstf/document/evidence-summary/breast-cancer--brca-testing-ovarian-cancer-screeni
    September 15, 2005 - What are the benefits of genetic counseling before testing? … What Are the Benefits of Genetic Counseling before Testing? … BRCA1 gene testing. … Genetic testing for cancer susceptibility: indications for genetic testing. SEER Data. … What are the benefits of genetic counseling before testing?

37. Archived: Evidence Summary: Breast and Ovarian Cancer: BRCA Genetic Testing, September 2005 | United States Preventive Services Taskforce
    www.uspreventiveservicestaskforce.org/uspstf/document/evidence-summary/breast-and-ovarian-cancer-brca-testing-screening-2005
    September 15, 2005 - What are the benefits of genetic counseling before testing? … What Are the Benefits of Genetic Counseling before Testing? … BRCA1 gene testing. … Genetic testing for cancer susceptibility: indications for genetic testing. SEER Data. … What are the benefits of genetic counseling before testing?

38. Screening for HIV: Recommendation Statement (pdf file)
    www.uspreventiveservicestaskforce.org/home/getfilebytoken/KWfaboZAt9KKoDMQbLvbbt
    June 20, 2019 - Reducing Obstetrician Barriers to Offering HIV Testing. … Update: serologic testing for HIV-1 antibody—United States, 1988 and 1989. … Voluntary HIV testing as part of routine medical care—Massachusetts, 2002. … Routinely recommended HIV testing at an urban urgent-care clinic—At- lanta, Georgia, 2000. … Prenatal and perinatal human immunodeficiency virus testing: expanded recommendations.

39. Recommendation: BRCA-Related Cancer: Risk Assessment, Genetic Counseling, and Genetic Testing | United States Preventive Services Taskforce
    www.uspreventiveservicestaskforce.org/uspstf/draft-update-summary/brca-related-cancer-risk-assessment-genetic-counseling-testing
    April 05, 2024 - Print BRCA-Related Cancer: Risk Assessment, Genetic Counseling, and Genetic Testing … Recommendation Statement for BRCA-Related Cancer: Risk Assessment, Genetic Counseling, and Genetic Testing

40. Final Research Plan: Cervical Cancer: Screening | United States Preventive Services Taskforce
    www.uspreventiveservicestaskforce.org/uspstf/document/final-research-plan/cervical-cancer-screening-adults-adolescents
    March 17, 2022 - of different cervical cancer screening strategies (i.e., test, mode of collection, and interval of testing … of different cervical cancer screening strategies (i.e., test, mode of collection, and interval of testing … Can extended genotyping and other triage technologies (e.g., DNA methylation testing and immunostaining … for p16/Ki67) for abnormal high-risk HPV or cytology screening results reduce burden of testing and … , vaginal, or urine Mode of collection: Self- or clinician-collected hrHPV samples Intervals of testing